Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL)

Clinical trials for Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL) explained in plain language.

Never miss a new study

Get alerted when new Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL) trials appear

Sign up with your email to follow new studies for Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Exosomes: the decoy receptors that may sabotage lymphoma treatment

Knowledge-focused Completed

This study investigates why some aggressive B-cell lymphomas stop responding to immunotherapy. Researchers are looking at tiny particles called exosomes that are released by tumor cells and may act as decoys, soaking up therapeutic antibodies before they can reach the cancer. By …

Matched conditions: LYMPHOMA, B-CELL, AGGRESSIVE NON-HODGKIN (B-NHL)

Sponsor: University Hospital, Limoges • Aim: Knowledge-focused

Last updated Jul 16, 2026 00:00 UTC

Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL)

Get alerted when new Lymphoma, B-cell, aggressive non-Hodgkin (B-NHL) trials appear

Exosomes: the decoy receptors that may sabotage lymphoma treatment